Takeda Pharmaceutical Company Limited (TAK) — 分析師展望 / 分析師共識目標價為. 基於 6 位分析師評級, 共識為 看漲 — 5 買入, 1 持有.
分析師預估 每股收益(EPS)為 $0.28 和 營收為 $25.85B (下一財年).
每股收益(EPS)歷史表現: 2024: 實際 $34.17 vs 預期 $0.28 (超預期 +12087.2%). 分析師準確度: 1%.
TAK 分析師評級
Buy
基於過去3個月內 6 位分析師對 Takeda Pharmaceutical Company Limited 的評級
EPS 預測 — TAK
1%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $34.17
vs Est $0.28
▲ 99.2% off
Profitability Outlook
Company is profitable but with thin earnings per share. Analysts forecast meaningful EPS growth ahead.
營收預測 — TAK
1%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $4,581.551B
vs Est $25.852B
▲ 99.4% off
Revenue Trend
Analysts forecast revenue contraction ahead.
